Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people whoโ€™ve been there
  • People who understand what youโ€™re going through
Sign Up Log In
Powered By
Real members of MyLymphomaTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.
A MyLymphomaTeam Member asked a question ๐Ÿ’ญ
September 14, 2024
 · 
Reactions
A MyLymphomaTeam Member
September 14, 2024
A MyLymphomaTeam Member
September 14, 2024
A MyLymphomaTeam Member

๐Ÿ™๐Ÿ™

September 19, 2024
A MyLymphomaTeam Member

Yes. I an 87 years old and was diagnosed with Stage 4 Splenic Marginal Zone Lymphome, CD20+, in July 2024 and was treated at MD Anderson in Houston with four infusions of Rituximab. At the time of diagnosis my only symptoms were fatigue (reported previously for about 5 years) and slowly decreasing (since 2018) WBC ,, RBC.. & Platelet counts.
At the time of diagnosis these were WBC 3.4 k/mcl, RBC 4.65 Mil/mcl, and Platelet count 96 k/mc. Since treatment in July 2024, I seem to be slightly less fatigued. Otherwise no post-treatment side effects so far. I am due for a PET Scan at the end of September 2024 which hopefully will show favorable results.

September 15, 2024

Related Questions

View All
A MyLymphomaTeam Member asked a question ๐Ÿ’ญ
Palm Coast, FL

A MyLymphomaTeam Member asked a question ๐Ÿ’ญ

Continue with Facebook
Continue with Google
By joining, you accept our Terms of Use, and acknowledge our collection, sharing, and use of your data in accordance with our Health Data and Privacy policies.
Already a member? Log In